Clinical importance of inducible beta-lactamases in gram-negative bacteria (Q39673645)

13 September 2017

1 reference

title

Clinical importance of inducible beta-lactamases in gram-negative bacteria (English)

1 reference

13 September 2017

Gram-negative bacteria

0 references

author name string

C C Sanders

series ordinal

1

1 reference

PubMed ID

3311737

13 September 2017

W E Sanders

series ordinal

2

1 reference

13 September 2017

1 August 1987

1 reference

European journal of clinical microbiology

13 September 2017

1 reference

13 September 2017

6

1 reference

13 September 2017

435-438

1 reference

13 September 2017

4

1 reference

Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

13 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Development of resistance to -lactam antibiotics with special reference to third-generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Moxalactam in nosocomial infections with Serratia marcescens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Effect of antibiotic use on the incidence of cephalosporin resistance in two Australian hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013106

Evaluation of disk approximation and agar dilution induction tests for demonstration of in vitro antagonism of cefotaxime by cefoxitin in Enterobacter species

21 January 2018

1 reference

12 December 2020

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

1 reference

12 December 2020

The nationwide nosocomial infection rate. A new need for vital statistics

1 reference

12 December 2020

Beta-lactamase alteration of beta-lactam inhibitory zones.

1 reference

12 December 2020

Pseudomonas aeruginosa isolates with modified beta-lactamase inducibility: effects on beta-lactam sensitivity

1 reference

12 December 2020

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

1 reference

12 December 2020

Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods

1 reference

12 December 2020

Moxalactam therapy for bacterial infections

1 reference

12 December 2020

Clinical consequences of development of resistance to third generation cephalosporins

1 reference

12 December 2020

Ability of newer beta-lactam antibiotics to induce beta-lactamase production in Enterobacter cloacae

1 reference

12 December 2020

Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics

1 reference

12 December 2020

Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics

1 reference

12 December 2020

Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia

1 reference

12 December 2020

Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients.

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins

1 reference

12 December 2020

Incidence of inducible beta-lactamases in gram-negative septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance

1 reference

12 December 2020

False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013106

1 reference

release_vd6gamlk4bblzpef7lo5rexikm

13 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vd6gamlk4bblzpef7lo5rexikm

24 November 2022

mapped directly with Wikidata item

PubMed ID

3311737

1 reference

PubMed ID

3311737